NO822171L - Viricide alfa,alfa-dialkyl adamantyletylaminer. - Google Patents
Viricide alfa,alfa-dialkyl adamantyletylaminer.Info
- Publication number
- NO822171L NO822171L NO822171A NO822171A NO822171L NO 822171 L NO822171 L NO 822171L NO 822171 A NO822171 A NO 822171A NO 822171 A NO822171 A NO 822171A NO 822171 L NO822171 L NO 822171L
- Authority
- NO
- Norway
- Prior art keywords
- alfa
- adamantyletylamines
- viricide
- dialkyl
- herpes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/277,777 US4351847A (en) | 1981-06-26 | 1981-06-26 | Antiviral alpha, alpha-dialkyl adamantylethylamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822171L true NO822171L (no) | 1982-12-27 |
Family
ID=23062307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822171A NO822171L (no) | 1981-06-26 | 1982-06-25 | Viricide alfa,alfa-dialkyl adamantyletylaminer. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4351847A (de) |
| EP (1) | EP0068365B1 (de) |
| JP (1) | JPS5841817A (de) |
| AT (1) | ATE23148T1 (de) |
| AU (1) | AU551678B2 (de) |
| CA (1) | CA1172170A (de) |
| DE (1) | DE3273975D1 (de) |
| DK (1) | DK287282A (de) |
| FI (1) | FI822282A7 (de) |
| IE (1) | IE53460B1 (de) |
| IL (1) | IL65787A (de) |
| NO (1) | NO822171L (de) |
| ZA (1) | ZA823699B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537908A (en) * | 1981-06-26 | 1985-08-27 | Pennwalt Corporation | Herpes II treatment |
| US4386105A (en) * | 1982-02-19 | 1983-05-31 | Pennwalt Corporation | Use of alpha, alpha-dialkyl adamantylethylamines to treat measles |
| US5506231A (en) * | 1989-03-31 | 1996-04-09 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy and blindness |
| US5334618A (en) * | 1991-04-04 | 1994-08-02 | The Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
| US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
| US5614560A (en) * | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
| WO1992017168A1 (en) * | 1991-04-04 | 1992-10-15 | The Children's Medical Center Corporation | Method of preventing nmda receptor-mediated neuronal damage |
| US6444702B1 (en) | 2000-02-22 | 2002-09-03 | Neuromolecular, Inc. | Aminoadamantane derivatives as therapeutic agents |
| CA3011538A1 (en) | 2016-01-18 | 2017-07-27 | Arisan Therapeutics | Adamantane derivatives for the treatment of filovirus infection |
| WO2019018185A1 (en) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS |
| EP4727967A1 (de) | 2023-06-16 | 2026-04-22 | Heidelberg ImmunoTherapeutics GmbH | Neuartiger anti-hsv-antikörper |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3352912A (en) * | 1963-07-24 | 1967-11-14 | Du Pont | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
| US4100170A (en) * | 1967-12-18 | 1978-07-11 | Pennwalt Corporation | Anorectic adamantane derivatives and method of using the same |
-
1981
- 1981-06-26 US US06/277,777 patent/US4351847A/en not_active Expired - Fee Related
-
1982
- 1982-05-14 IL IL65787A patent/IL65787A/xx unknown
- 1982-05-26 IE IE1258/82A patent/IE53460B1/en unknown
- 1982-05-27 ZA ZA823699A patent/ZA823699B/xx unknown
- 1982-06-02 AU AU84413/82A patent/AU551678B2/en not_active Ceased
- 1982-06-11 CA CA000405048A patent/CA1172170A/en not_active Expired
- 1982-06-18 EP EP82105382A patent/EP0068365B1/de not_active Expired
- 1982-06-18 AT AT82105382T patent/ATE23148T1/de not_active IP Right Cessation
- 1982-06-18 DE DE8282105382T patent/DE3273975D1/de not_active Expired
- 1982-06-24 FI FI822282A patent/FI822282A7/fi not_active Application Discontinuation
- 1982-06-25 JP JP57108572A patent/JPS5841817A/ja active Pending
- 1982-06-25 NO NO822171A patent/NO822171L/no unknown
- 1982-06-25 DK DK287282A patent/DK287282A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU551678B2 (en) | 1986-05-08 |
| US4351847A (en) | 1982-09-28 |
| CA1172170A (en) | 1984-08-07 |
| DK287282A (da) | 1982-12-27 |
| EP0068365A1 (de) | 1983-01-05 |
| JPS5841817A (ja) | 1983-03-11 |
| IE53460B1 (en) | 1988-11-23 |
| IE821258L (en) | 1982-12-26 |
| FI822282L (fi) | 1982-12-27 |
| ZA823699B (en) | 1983-05-25 |
| DE3273975D1 (de) | 1986-12-04 |
| FI822282A0 (fi) | 1982-06-24 |
| EP0068365B1 (de) | 1986-10-29 |
| AU8441382A (en) | 1983-01-06 |
| FI822282A7 (fi) | 1982-12-27 |
| IL65787A (en) | 1985-05-31 |
| ATE23148T1 (de) | 1986-11-15 |
| IL65787A0 (en) | 1982-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
| GEP19970949B (en) | Antiemetic and tranquilizing agent for prevention of sea sickness | |
| ES8403128A1 (es) | "un procedimiento para preparar derivados de purina". | |
| NO822171L (no) | Viricide alfa,alfa-dialkyl adamantyletylaminer. | |
| FI810389L (fi) | Foerfarande foer framstaellning av substituerade imidazolderivat | |
| EP0135312B1 (de) | Antivirale Zusammensetzungen | |
| FI823871L (fi) | Foerfarande foer framstaellning av substituerade imidazolderivat | |
| ES8401960A1 (es) | Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas. | |
| DE3144689A1 (de) | Antivirusmittel | |
| JPS5489036A (en) | Remedy and preventive for hypersensitivity to light | |
| ES8503649A1 (es) | Procedimiento para preparar esteres de acidos benzosulfonicos substituidos | |
| DE3111770A1 (de) | Verwendung von dimercaptopropansulfonsaeure und dimercaptobernsteinsaeure zur herstellung von pharmazeutischen mitteln | |
| DE3365954D1 (en) | The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles | |
| US5262174A (en) | Anti-viral compositions | |
| ES8303299A1 (es) | Procedimiento de preparacion de un nuevo derivado de acido benzamido-alquil-hidroxamico. | |
| IL64839A (en) | N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them | |
| JPS54125663A (en) | Carcinostatic agent and novel compound having carcinostatic activity | |
| GB1464082A (en) | Pharmaceutical 'ompositions containing benzylamines | |
| JPS55149213A (en) | Remedy of dna for viral disease | |
| ES8101062A1 (es) | Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos. | |
| Al-Khayat et al. | Some studies on the effects of ambilhar on mobilisation and excretion of lead | |
| DE1807733A1 (de) | Basisches Wismutinosithexaphosphat | |
| JPS55139366A (en) | Piperazine compound, its salt, and their preparation | |
| JPS5639018A (en) | Remedy for cancer |